Tillotts Pharma acquired by Zeria Pharmaceutical

Sep. 2009

Client: Tillotts is a leading gastroenterology products pharmaceutical company - Its lead product is Asacol, which it markets under exclusive rights in 44 countries

Role: Edgemont Partners and IMI Consulting acted as exclusive financial advisors to Tillotts Pharma in its sale to Zeria Pharmaceutical

Location: Ziefen, Switzerland

Sector: Pharmaceutical Services

Lead Banker: David Blume

View Press Release

tillotts pharma logo

acquired by

zeria pharmaceutical co logo
Get In Touch